Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose spironolactone for acne in trans men
TCTR20250417002Phase 2Completed
- Sponsor
- Ramathibodi Hospital
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of spironolactone in acne vulgaris, sponsored by Ramathibodi Hospital. Started Nov 2021; status: completed.
02
Drugs
spironolactone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on TCTR20250417002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250417002.